Perini, V., Schacke, M., Liddle, P., Vilchez Larrea, S. C., Keszenman, D. J., & Lafon Hughes, L. (2020). PARP Inhibitor Olaparib Causes No Potentiation of the Bleomycin Effect in VERO Cells, Even in the Presence of Pooled ATM, DNA-PK, and LigIV Inhibitors. Web
Citación estilo ChicagoPerini, Valentina, Michelle Schacke, Pablo Liddle, Salomé Catalina Vilchez Larrea, Deborah J. Keszenman, and Laura Lafon Hughes. PARP Inhibitor Olaparib Causes No Potentiation of the Bleomycin Effect in VERO Cells, Even in the Presence of Pooled ATM, DNA-PK, and LigIV Inhibitors. 2020.
Cita MLAPerini, Valentina, et al. PARP Inhibitor Olaparib Causes No Potentiation of the Bleomycin Effect in VERO Cells, Even in the Presence of Pooled ATM, DNA-PK, and LigIV Inhibitors. 2020.